Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium

Fig. 3

Hazard ratios for HbA1c and outcomes: cardiovascular mortality, cardiovascular disease, and overall mortality, stratified into age groups. HbA1c was used as continuous variable in mmol/mol. Hazard ratios are presented per 10 mmol/mol increase. The Cox models for the three endpoints were adjusted for age (time scale), sex and cohort (strata), and CVRFs, smoking status, BMI, systolic blood pressure, DM, DM treatment, and total cholesterol to HDL cholesterol ratio. The p-value for interaction is for an interaction between age groups and HbA1c

Back to article page